Research Article
Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up
Table 4
Efficacy and safety during follow-up.
| | | <12-month follow-up | ≥12-month follow-up |
| | Number (n) | 166 | 144 | | Complications, n (%) | | | | TIA | 1 (0.6%) | 3 (2.1%) | | Stroke | 2 (1.2%) | 1 (0.7%) | | AF | 9 (5.4%) | 6 (4.4%) | | Death | 0 (0%) | 6 (4.4%) | | TTE available (n) | 163 (98.2%) | 71 (49.3%) | | LRS, n (%) | 0 (0%) | 0 (0%) | | RLS, n (%) | | | | No shunt | 113 (69.3%) | 49 (69.0%) | | Minimal | 30 (18.5%) | 16 (22.5%) | | Moderate | 15 (9.2%) | 5 (7.1%) | | Severe | 5 (3.0%) | 1 (1.4%) |
|
|
TIA, transient ischemic attack; AF, atrial fibrillation; TTE, transthoracic echocardiography; RLS, right-to-left shunt.
|
